Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 6 | 2022 | 678 | 1.440 |
Why?
|
| Quinolines | 1 | 2020 | 60 | 0.760 |
Why?
|
| Protein Phosphatase 1 | 3 | 2022 | 58 | 0.570 |
Why?
|
| Transcription, Genetic | 4 | 2022 | 550 | 0.490 |
Why?
|
| Anemia, Sickle Cell | 3 | 2021 | 169 | 0.450 |
Why?
|
| Gene Expression Regulation, Viral | 5 | 2021 | 108 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2021 | 160 | 0.430 |
Why?
|
| Virus Replication | 5 | 2021 | 261 | 0.370 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 52 | 0.370 |
Why?
|
| Ebolavirus | 2 | 2019 | 42 | 0.340 |
Why?
|
| Phosphorylation | 5 | 2022 | 878 | 0.330 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 9 | 3 | 2021 | 37 | 0.220 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2021 | 19 | 0.210 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 15 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 183 | 0.200 |
Why?
|
| Viral Core Proteins | 1 | 2019 | 10 | 0.180 |
Why?
|
| Nucleoproteins | 1 | 2019 | 10 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 229 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2018 | 30 | 0.170 |
Why?
|
| Orosomucoid | 1 | 2018 | 12 | 0.160 |
Why?
|
| Serine | 1 | 2018 | 72 | 0.160 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 15 | 0.160 |
Why?
|
| Proteins | 1 | 2020 | 352 | 0.160 |
Why?
|
| Humans | 11 | 2022 | 34853 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2018 | 148 | 0.150 |
Why?
|
| Mice | 3 | 2022 | 5668 | 0.140 |
Why?
|
| HIV Infections | 2 | 2021 | 2207 | 0.140 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2015 | 55 | 0.130 |
Why?
|
| Curcumin | 1 | 2015 | 66 | 0.130 |
Why?
|
| Iron Chelating Agents | 1 | 2014 | 21 | 0.130 |
Why?
|
| Cyclin T | 3 | 2021 | 16 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2014 | 40 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 341 | 0.110 |
Why?
|
| Animals | 4 | 2022 | 14307 | 0.110 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 394 | 0.100 |
Why?
|
| Early Diagnosis | 2 | 2021 | 62 | 0.090 |
Why?
|
| RNA, Viral | 2 | 2021 | 287 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2019 | 172 | 0.080 |
Why?
|
| Disease Progression | 2 | 2021 | 580 | 0.080 |
Why?
|
| Drug Stability | 2 | 2018 | 110 | 0.070 |
Why?
|
| Protein Binding | 2 | 2021 | 913 | 0.070 |
Why?
|
| Proteomics | 2 | 2019 | 302 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1442 | 0.060 |
Why?
|
| Kringles | 1 | 2021 | 5 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 43 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 137 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 224 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2019 | 9 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 29 | 0.050 |
Why?
|
| Viral Matrix Proteins | 1 | 2019 | 17 | 0.050 |
Why?
|
| Vero Cells | 1 | 2019 | 90 | 0.040 |
Why?
|
| Chiroptera | 1 | 2019 | 20 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 67 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2019 | 77 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 707 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2018 | 97 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 639 | 0.040 |
Why?
|
| Hemoglobinuria | 1 | 2018 | 3 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 54 | 0.040 |
Why?
|
| Hemolysis | 1 | 2018 | 39 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 161 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2018 | 350 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 179 | 0.040 |
Why?
|
| Male | 3 | 2021 | 18870 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2015 | 48 | 0.030 |
Why?
|
| Female | 3 | 2021 | 19873 | 0.030 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2015 | 33 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 46 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 52 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 608 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 9642 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1124 | 0.030 |
Why?
|
| Cyclin A | 1 | 2014 | 5 | 0.030 |
Why?
|
| Reverse Transcription | 1 | 2014 | 16 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 642 | 0.030 |
Why?
|
| Cyclin E | 1 | 2014 | 13 | 0.030 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 18 | 0.030 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 15 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 751 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 37 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 496 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 11034 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2018 | 653 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 1023 | 0.030 |
Why?
|
| Inflammation | 1 | 2018 | 577 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 4012 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 818 | 0.030 |
Why?
|
| Cell Line | 1 | 2014 | 1289 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 5035 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1152 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 6448 | 0.020 |
Why?
|